AB42/AB40 Ratio: A Critical Biomarker in Alzheimer’s Disease Diagnosis The AB42/AB40 ratio is an advanced cerebrospinal fluid (CSF) biomarker that measures the balance between β-Amyloid (1-42) and β-Amyloid (1-40), two peptides derived from the amyloid precursor protein (APP). This ratio plays a crucial role in diagnosing Alzheimer’s disease (AD) and differentiating it from other neurodegenerative or dementia-related conditions. What Is the AB42/AB40 Ratio? β-Amyloid (1-42): This peptide aggregates in the brain to form amyloid plaques, a hallmark of Alzheimer’s disease. Reduced levels in CSF reflect its deposition in the brain. β-Amyloid (1-40): The most abundant amyloid peptide in CSF, it remains relatively unaffected by plaque formation and serves as a stable reference for total amyloid production. The AB42/AB40 ratio normalizes the levels of β-Amyloid (1-42) to β-Amyloid (1-40), providing a more reliable measure of amyloid plaque burden. This ratio reduces the impact of individual variability in amyloid production and factors such as CSF protein levels or sample dilution. Reference ranges of AB42/AB40 Ratio: The reference range for the AB42/AB40 ratio can vary depending on the laboratory and assay method used, but generally, the following thresholds are applied: Normal Range (Low Risk for Alzheimer’s): ≥ 0.16 This indicates a healthy balance of β-Amyloid (1-42) and β-Amyloid (1-40), with no significant amyloid plaque deposition. Abnormal Range (High Risk for Alzheimer’s): < 0.16 A reduced ratio below this threshold strongly suggests amyloid plaque formation in the brain and is commonly associated with Alzheimer’s disease. Some studies or labs may use slightly different cutoffs, such as 0.068, particularly in research settings or based on assay-specific validations. Always interpret results in the context of additional biomarkers (e.g., total tau, pTau) and clinical findings. Clinical Implications of a Reduced AB42/AB40 Ratio 1. Alzheimer’s Disease Diagnosis A low AB42/AB40 ratio is strongly indicative of Alzheimer’s disease, reflecting the sequestration of β-Amyloid (1-42) in brain plaques. Ratios below 0.068 are typically associated with a high likelihood of Alzheimer’s pathology. 2. Differentiating Alzheimer’s from Other Conditions The AB42/AB40 ratio is more specific to Alzheimer’s disease than β-Amyloid (1-42) alone, helping to distinguish it from other dementias or neurodegenerative disorders like vascular dementia or frontotemporal dementia. 3. Mild Cognitive Impairment (MCI) In individuals with MCI, a reduced AB42/AB40 ratio suggests a higher risk of progression to Alzheimer’s disease, allowing for earlier intervention. Benefits of the AB42/AB40 Ratio Improved Diagnostic Accuracy: The ratio is less influenced by individual variability in β-Amyloid production compared to β-Amyloid (1-42) alone. Early Detection: Changes in the AB42/AB40 ratio often precede the onset of cognitive symptoms by years. High Sensitivity and Specificity: Studies have shown the ratio to have 77% sensitivity and 85% specificity for Alzheimer’s disease diagnosis. Next Steps After a Reduced AB42/AB40 Ratio If the AB42/AB40 ratio is reduced, further diagnostic evaluations may include: Tau Protein Testing: To assess neuronal damage (total tau) and tau hyperphosphorylation (pTau). Imaging Studies: Such as amyloid PET scans to visualize amyloid plaques in the brain. Cognitive Testing: To evaluate memory and cognitive function. By combining the AB42/AB40 ratio with other biomarkers, clinicians can achieve a more accurate and early diagnosis of Alzheimer’s disease, facilitating effective treatment and care planning. This biomarker is a vital tool in understanding Alzheimer’s disease progression, offering insights into amyloid plaque burden and distinguishing it from other conditions. Early identification through the AB42/AB40 ratio provides an opportunity for timely intervention and better patient outcomes.
Cerebrospinal Fluid (CSF) Analysis
A CSF analysis, also known as spinal fluid analysis or CSF testing, comprises a set of tests that utilize a sample of cerebrospinal fluid to diagnose various conditions affecting the brain, spinal cord, and the central nervous system. These tests are valuable for identifying neurological diseases, infections, and other health issues that may impact CNS function.
CSF plays a crucial role as a protective cushion for the brain and spinal cord, guarding them against sudden impacts and injuries. Additionally, it serves as a waste disposal system, aiding in the removal of metabolic waste products from the brain. This function is essential for maintaining the optimal functioning of the central nervous system.
Biomarkers in this category
34 biomarkers · optimal ranges shown
Albumin, CSF – What It Means and Why It's Measured Albumin, CSF refers to the measurement of albumin levels in cerebrospinal fluid (CSF). Albumin is a protein made by the liver that normally circulates in the blood. In healthy individuals, only very small amounts of albumin pass from the blood into the CSF due to the protective blood-brain barrier (BBB). Why Is Albumin Measured in CSF? Measuring albumin in the CSF helps assess the integrity of the blood-brain barrier. The blood-brain barrier is a selective membrane that controls which substances can enter the brain from the bloodstream. This test is commonly used to evaluate: Suspected central nervous system (CNS) infections or inflammation Neurological conditions such as multiple sclerosis Trauma, stroke, or tumors that may disrupt the BBB Conditions causing increased CSF protein levels What Does a High Albumin, CSF Level Mean? An elevated albumin level in CSF often indicates that the blood-brain barrier is compromised, allowing more albumin to leak into the CSF. Possible causes include: Meningitis or encephalitis (infections of the brain or spinal cord) Multiple sclerosis or other autoimmune CNS disorders Brain or spinal cord tumors Traumatic brain injury Stroke or ischemia Diabetic neuropathy A high albumin CSF level is often assessed together with the CSF/serum albumin ratio to determine whether the source of increased protein is due to barrier dysfunction or increased production within the CNS. What Does a Low Albumin, CSF Level Mean? A low albumin concentration in CSF is generally considered normal and reflects an intact and properly functioning blood-brain barrier. It is rarely a cause for concern on its own. Summary Albumin, CSF is a useful marker for evaluating the health of the blood-brain barrier and identifying potential neurological disorders. High levels may indicate inflammation, infection, trauma, or other conditions that affect the brain and spinal cord. Low levels are usually normal. This test is most informative when considered alongside other CSF markers and clinical findings.
Cerebrospinal fluid (CSF) is a clear, watery liquid that flows around the brain and spinal cord, surrounding and protecting them. CSF testing is performed to evaluate the level or concentration of different substances and cells in CSF in order to diagnose conditions affecting the brain and spinal cord (central nervous system). The appearance of the sample of CSF is usually compared to a sample of water. Color of the fluid - normal is clear and colorless. Changes in the color of the CSF are not diagnostic but may point to additional substances in the fluid. Yellow, orange, or pink CSF may indicate the breakdown of blood cells due to bleeding into the CSF or the presence of bilirubin. Green CSF may also sometimes be seen with bilirubin or infection. Turbidity - cloudy or turbid CSF may indicate the presence of white or red blood cells, microbes, or an increase in protein levels. Viscosity - normal CSF will have the same consistency as water. CSF that is “thicker” may be seen in people with certain types of cancers or meningitis. Conditions associated with changes in the appearance of CSF include the following: Infectious meningitis – Turbid, milky, cloudy CSF samples Hemorrhage or traumatic tap – Xanthochromic CSF samples with increased hemoglobin Kernicterus - Xanthochromic CSF samples with increased bilirubin Meningeal melanosarcoma – Xanthochromic CSF samples with increased melanin Disorders affecting blood-brain barrier - Cloudy CSF samples with increased proteins (above 150 mg/dL) and albumin and IgG Xanthochromia is the term used for any kind of discoloration of CSF (pink, yellow, orange). Multiple conditions are associated with xanthochromia: traumatic tap, presence of carotene, melanoma and increased bilirubin concentration (bilirubin concentration will also be elevated in serum and patients are often jaundiced) due to liver diseases, hemolytic diseases (also increased free hemoglobin concentration) and inborn errors of metabolism. Note that normal CSF samples should be colorless, clear, like water. If CSF samples are centrifuged immediately, xanthochromia due to traumatic tap should not occur. However, if CSF samples are carefully centrifuged immediately and the supernatant is still xanthochromic, this indicates that bleeding may have occurred 2-4 hours before sample collection. Furthermore, in about 10% of patients with subarachnoid hemorrhage, the CSF samples might be clear if the samples are collected 12 hours after the hemorrhage occurred. Typically, high levels of oxyhemoglobin occur in CSF fluid obtained through a traumatic lumbar puncture, in which red blood cells enter the subarachnoid space via direct needle puncture. This frustrates the ability to determine whether xanthochromia, and thus subarachnoid hemorrhage, is present.
Crenated erythrocytes are red blood cells (RBCs) with an irregular, spiked appearance caused by cellular dehydration or exposure to hypertonic environments. In cerebrospinal fluid (CSF), their presence typically reflects structural damage or mechanical disruption to blood vessels, leading to RBC breakdown or abnormal morphology. What Causes Crenated Erythrocytes in CSF? Traumatic Lumbar Puncture A common cause of crenated erythrocytes in CSF is trauma during sample collection. RBCs can become crenated very soon after entering the CSF, even in traumatic taps. Intracranial Hemorrhage or Subarachnoid Hemorrhage (SAH) In conditions such as SAH, RBCs in the CSF undergo crenation and lysis within hours. About 6 hours or more after SAH, RBCs become crenated and lyse, resulting in xanthochromic CSF supernatant. Infections or Inflammation Severe CNS infections, such as meningitis or encephalitis, can damage blood vessels, allowing RBCs to enter the CSF. CSF Dynamics CSF is produced at a rate of about 500 mL/day and turns over 3-4 times daily. This turnover affects the presence and condition of RBCs in the CSF. Clinical Implications The presence of crenated erythrocytes in CSF suggests blood entry into the CSF space. However, it's important to note that crenated RBCs alone are not a reliable indicator for distinguishing between true bleeding and traumatic taps. They can appear in both scenarios, limiting their diagnostic value for conditions like SAH.Xanthochromia, the yellow discoloration of CSF supernatant due to hemoglobin breakdown products, is a more reliable indicator of older hemorrhages, particularly in SAH diagnosis.
cerebrospinal fluid glucose
What it is: The CSF IgG Index is a specialized test that measures the amount of immunoglobulin G (IgG) in the cerebrospinal fluid (CSF) relative to the amount in the blood. This index helps determine whether IgG is being produced within the central nervous system (CNS)—a key sign of inflammation or immune system activity in the brain or spinal cord. Why it matters: An elevated CSF IgG Index suggests that the body is producing IgG inside the CNS, which is often associated with neurological conditions like multiple sclerosis (MS), central nervous system infections, or chronic inflammatory diseases. A normal index typically rules out significant intrathecal (within the CNS) IgG production. How it's calculated: The index is calculated using the formula: (CSF IgG / Serum IgG) ÷ (CSF Albumin / Serum Albumin) This adjusts for how much IgG might passively leak into the CSF from the bloodstream and helps isolate what’s being actively produced in the CNS. When it’s used: Doctors may order this test if you have symptoms like: Numbness, tingling, or weakness Vision changes Balance or coordination problems Signs of CNS infection or inflammation Interpretation: High CSF IgG Index (>0.7–0.85, depending on lab): Suggests intrathecal IgG production; often seen in MS or chronic CNS infections Normal or low index: No significant CNS IgG production; can help rule out certain diseases Takeaway: The CSF IgG Index is a valuable marker for detecting immune activity within the brain or spinal cord, often helping diagnose or monitor diseases like multiple sclerosis. Results should always be interpreted alongside other tests (e.g., oligoclonal bands, MRI) and clinical findings by a healthcare provider.
Cerebrospinal fluid marker measuring red blood cell contamination or hemorrhage.
Protein levels in cerebrospinal fluid
white blood cells in cerebrospinal fluid
CSF/Serum Albumin Index The CSF/Serum Albumin Index is a key diagnostic tool used to assess the integrity of the blood-brain barrier (BBB). It compares albumin concentrations in the cerebrospinal fluid (CSF) and serum. Since albumin is produced exclusively in the liver and not within the central nervous system (CNS), its presence in the CSF indicates passive diffusion across the BBB. An elevated index suggests increased permeability or disruption of the barrier, making it a reliable marker for BBB dysfunction. Clinical Applications This index is used to evaluate a wide range of neurological conditions, including: Inflammatory CNS diseases (e.g., multiple sclerosis, neurosyphilis) CNS infections (e.g., bacterial or viral meningitis, encephalitis) Traumatic brain injury or hemorrhage Neurodegenerative disorders (e.g., Alzheimer’s disease, vascular dementia) Autoimmune conditions (e.g., CNS involvement in lupus or sarcoidosis) Reference Ranges and Interpretation Age-adjusted thresholds: <6.8 for individuals under 45 years <10.2 for individuals over 45 years General impairment categories: <9: Intact BBB 9–14: Slight impairment 14–30: Moderate impairment 30–100: Severe impairment >100: Complete BBB breakdown Elevated values may indicate: Acute CNS infections (e.g., bacterial meningitis) Autoimmune or inflammatory CNS conditions (e.g., multiple sclerosis, autoimmune encephalitis) Tumors or mechanical trauma (e.g., spinal cord injury, hemorrhage) Key Considerations Paired sample testing: Both serum and CSF must be collected at the same time for accurate calculation. Interpretation in context: Best used alongside the IgG Index (for intrathecal antibody production) and oligoclonal banding. Limitations: Reflects both blood-CSF barrier function (choroid plexus) and cerebrovascular endothelial integrity—cannot distinguish between them. Takeaway The CSF/Serum Albumin Index is an essential biomarker for detecting blood-brain barrier dysfunction, helping diagnose and monitor CNS infections, autoimmune diseases, trauma, and neurodegeneration. Accurate interpretation requires age-based reference ranges and correlation with other laboratory and clinical findings.
Erythrocytes, or red blood cells (RBCs), are generally absent in cerebrospinal fluid (CSF) under normal conditions. Their presence in the CSF often indicates bleeding, trauma, or other pathological processes affecting the central nervous system (CNS). Evaluating erythrocytes in CSF is a crucial step in diagnosing conditions like subarachnoid hemorrhage, traumatic injury, or inflammation. Normal Levels of Erythrocytes in CSF Normal CSF: Contains no erythrocytes under typical conditions (0 cells/μL). What Elevated Erythrocytes in CSF Mean The presence of erythrocytes in CSF can result from one of the following scenarios: 1. Subarachnoid Hemorrhage (SAH) A hallmark of subarachnoid hemorrhage, which is bleeding into the space between the brain and the thin tissues covering it. CSF collected in such cases often appears blood-stained. Differentiation between a true hemorrhage and a traumatic lumbar puncture (see below) is performed using tests such as the xanthochromia test (yellow discoloration due to hemoglobin breakdown). 2. Traumatic Lumbar Puncture Blood contamination during the collection of CSF from a lumbar puncture can lead to the appearance of erythrocytes in the fluid. Typically, the number of erythrocytes decreases across sequentially collected tubes, distinguishing it from a subarachnoid hemorrhage. 3. Inflammatory or Infectious Conditions Severe meningitis or encephalitis can damage blood vessels, allowing erythrocytes to leak into the CSF. 4. Intracranial Hemorrhage Includes bleeding caused by trauma, ruptured aneurysms, or vascular malformations. Often accompanied by elevated CSF protein and signs of increased intracranial pressure. 5. CNS Tumors Certain tumors, such as brain metastases or primary CNS cancers, can invade blood vessels, causing bleeding and resulting in erythrocytes in the CSF. Distinguishing Causes of Erythrocytes in CSF To differentiate causes, additional tests may be performed: Xanthochromia: Indicates older bleeding (hemoglobin breakdown into bilirubin). CSF Protein and Glucose Analysis: Changes can provide clues to accompanying conditions (e.g., high protein in hemorrhages or malignancies). Clinical Implications The presence of erythrocytes in CSF is a critical diagnostic clue. For instance: Persistent erythrocytes in all CSF tubes collected during a lumbar puncture suggest a true hemorrhage. A decreasing number of erythrocytes across tubes is indicative of a traumatic puncture. Next Steps If erythrocytes are detected in CSF, further investigations, such as imaging (CT or MRI) and repeat lumbar punctures, may be necessary to confirm the cause and guide treatment. Always consult a healthcare provider for a comprehensive evaluation in the context of symptoms and other test results.
IgG, Quant, CSF – What It Means and Why It Matters IgG, Quant, CSF stands for Immunoglobulin G, Quantitative, Cerebrospinal Fluid. This test measures the concentration of IgG, a type of antibody, in your cerebrospinal fluid (CSF)—the clear fluid that surrounds your brain and spinal cord. What is IgG? Immunoglobulin G (IgG) is the most abundant antibody in the body. It plays a critical role in immune defense by identifying and neutralizing viruses, bacteria, and other foreign substances. IgG is normally found in the blood but can also be present in small amounts in the CSF. Why Measure IgG in CSF? This test helps detect abnormal immune activity or inflammation within the central nervous system (CNS). It's often used in the diagnostic workup of: Multiple sclerosis (MS) Chronic CNS infections (e.g., neurosyphilis, Lyme disease, viral meningitis) Autoimmune diseases affecting the brain or spinal cord Neurological complications of systemic diseases What Does a High IgG, CSF Level Mean? Elevated IgG in the CSF may suggest: Multiple sclerosis (MS) or other demyelinating diseases Chronic inflammation or immune activation in the CNS Intrathecal synthesis of IgG (i.e., the body is producing IgG within the CNS) In MS, this test is often interpreted alongside oligoclonal bands and the IgG index, which compare CSF IgG to serum IgG to determine whether the elevated antibodies are coming from within the CNS. What Does a Low IgG, CSF Level Mean? A low level of IgG in the CSF is typically not concerning on its own and may simply reflect: Normal immune activity Reduced CSF sampling or protein levels Rarely, impaired immune response in immunocompromised individuals Summary IgG, Quant, CSF is an important diagnostic tool for detecting immune activity in the brain and spinal cord. Elevated levels can signal neurological diseases such as multiple sclerosis or chronic infections. Interpretation of this marker should always be done alongside other CSF findings and clinical information.
The IgG Synthesis Rate (CSF) measures how much immunoglobulin G (IgG) is being actively produced within the central nervous system (CNS)—specifically the brain and spinal cord. It helps determine whether the immune system is generating antibodies inside the CNS, which can signal inflammation, infection, or autoimmune activity affecting the brain or spinal cord. Why it matters: While some IgG naturally crosses from the blood into the cerebrospinal fluid (CSF), an elevated IgG synthesis rate means the immune system is producing extra IgG locally within the CNS. This is a hallmark of conditions like multiple sclerosis (MS), chronic CNS infections, or autoimmune neuroinflammatory diseases. How it’s calculated: The IgG synthesis rate is calculated using levels of: IgG in the CSF and serum Albumin in the CSF and serum The result estimates how much IgG is being produced inside the CNS, rather than just leaking in from the bloodstream. What an Elevated IgG Synthesis Rate May Indicate: Multiple Sclerosis (MS): Often shows both increased synthesis rate and positive oligoclonal bands. Chronic CNS Infections: Such as HIV, syphilis, Lyme neuroborreliosis, or tuberculous meningitis. Autoimmune Diseases: Inflammatory conditions like neurosarcoidosis or lupus with CNS involvement. Other CNS disorders: Chronic inflammatory demyelinating polyneuropathy (CIDP), encephalitis. Reference Range and Interpretation: A normal IgG synthesis rate varies slightly by lab but is typically below 3.3 mg/day. A higher value suggests active immune response in the CNS and should be evaluated alongside clinical symptoms and additional tests like MRI or oligoclonal bands. Takeaway: The CSF IgG Synthesis Rate is a valuable tool in diagnosing and monitoring diseases that involve the immune system attacking or reacting within the brain or spinal cord. Elevated levels point to ongoing antibody production within the CNS, which can help confirm conditions like MS or chronic neurological infections. Interpretation should always be done by a healthcare professional in the context of a full clinical picture.
IgG/Alb Ratio, CSF – What It Means and Why It's Important The IgG/Alb Ratio, CSF (Immunoglobulin G to Albumin Ratio in Cerebrospinal Fluid) helps evaluate immune activity within the central nervous system (CNS) and the integrity of the blood-brain barrier (BBB). It compares the levels of two key proteins—IgG and albumin—in the CSF. This ratio is particularly useful for assessing whether elevated IgG levels in the CSF are due to local immune production in the brain and spinal cord or due to leakage from the bloodstream caused by a disrupted blood-brain barrier. What Does the IgG/Albumin Ratio Measure? IgG (Immunoglobulin G): An antibody involved in immune responses. Albumin: A protein that normally remains in the bloodstream unless the blood-brain barrier is compromised. The IgG/Alb Ratio provides insight into: Intrathecal IgG synthesis (production of antibodies within the CNS) Blood-brain barrier function This ratio is often interpreted alongside the IgG Index and oligoclonal band testing in evaluating neurological diseases. What Does a High IgG/Alb Ratio in CSF Indicate? A high IgG/Albumin ratio suggests that the immune system is actively producing IgG within the CNS. This finding may be associated with: Multiple sclerosis (MS) Chronic CNS infections (e.g., neurosyphilis, Lyme disease, HIV-related neurological disease) Autoimmune disorders affecting the brain or spinal cord In these conditions, immune cells inside the CNS produce antibodies independently of the rest of the body, leading to a disproportionately high IgG level in the CSF compared to albumin. What Does a Low IgG/Alb Ratio in CSF Mean? A low or normal IgG/Alb ratio typically means: No abnormal antibody production in the CNS Intact blood-brain barrier CSF IgG levels are proportionate to what’s expected based on albumin leakage from the bloodstream This is generally considered a normal or non-pathological result. Summary The IgG/Alb Ratio, CSF helps distinguish whether elevated IgG in the cerebrospinal fluid is due to local immune activity or simply leakage through a damaged blood-brain barrier. A high ratio often points to neurological conditions like multiple sclerosis or chronic CNS infections. A normal or low ratio suggests stable immune activity and barrier integrity.
a significant biomarker for evaluating various central nervous system (CNS) conditions
provide insights into the immunological and pathological status of the CNS
Lymphocytes (Lymphs) in cerebrospinal fluid (CSF) are an important marker often assessed during lab tests to evaluate the health of the central nervous system. Lymphocytes are a type of white blood cell that plays a critical role in the immune response. In the CSF, elevated levels of lymphs can indicate inflammation or infection, such as viral meningitis, autoimmune diseases, or certain cancers like lymphoma. Normal lymphocyte levels in the CSF typically suggest a healthy central nervous system. However, deviations from normal ranges may prompt further investigation to determine the underlying cause of the immune response within the brain and spinal cord.
The share of spinal fluid white cells that are monocytes.
Monos on a spinal fluid report means monocytes. They are normal residents of CSF, with an adult reference range of 15-45%.
Non-Crenated Erythrocytes (CSF) refer to red blood cells (RBCs) in cerebrospinal fluid (CSF) that maintain their normal, smooth, biconcave shape. Their presence typically indicates a more recent or acute introduction of blood into the CSF, such as from a traumatic injury, subarachnoid hemorrhage, or traumatic lumbar puncture. Unlike crenated erythrocytes, which form after prolonged exposure to CSF or osmotic stress, non-crenated erythrocytes suggest fresh bleeding or damage. Elevated levels of non-crenated erythrocytes often accompany other markers of acute trauma or hemorrhage and require further evaluation with imaging studies and additional CSF analysis to identify the source and extent of the underlying issue.
Nucleated cells on a spinal fluid report are the white cells counted in cerebrospinal fluid, the fluid around the brain and spinal cord.
can be related to MS
Phosphorylated Tau 181 (pTau181) is a biomarker measured in cerebrospinal fluid (CSF) to assess the presence of abnormal tau protein associated with neurodegenerative diseases, particularly Alzheimer’s disease. Tau is a protein involved in stabilizing microtubules within neurons, but when abnormally phosphorylated at specific sites, such as threonine 181, it becomes dysfunctional and contributes to the formation of neurofibrillary tangles—a hallmark of Alzheimer’s pathology. Elevated pTau181 levels in CSF are strongly indicative of tau-related neurodegeneration and help distinguish Alzheimer’s disease from other types of dementia or neurodegenerative conditions. When analyzed alongside total tau and amyloid-beta (Aβ42) levels, pTau181 improves diagnostic accuracy for early Alzheimer’s, aiding in the differentiation of Alzheimer’s from other disorders like frontotemporal dementia. Elevated pTau181 levels reflect not only neuronal damage but also ongoing tau hyperphosphorylation, making it a critical tool for both diagnosis and monitoring disease progression.
Polymorphonuclear Cells (PMNs) in Cerebrospinal Fluid (CSF) Polymorphonuclear cells (PMNs), primarily neutrophils, are a type of white blood cell crucial in the body's immune response to bacterial infections. Their presence in cerebrospinal fluid (CSF) often indicates inflammation or infection affecting the central nervous system (CNS). Normal Levels of PMNs in CSF In healthy individuals, CSF typically contains 0-5 PMNs/µL. The blood-brain barrier normally restricts immune cells from entering the CNS unless there's an abnormality. What Elevated PMNs in CSF Mean An increased percentage of PMNs in CSF, known as neutrophilic pleocytosis, typically indicates an acute inflammatory or infectious process in the CNS. Common causes include: Bacterial Meningitis: Hallmark: PMN predominance in CSF (often >80% of total white blood cells) Associated findings: Elevated CSF protein, decreased glucose levels, positive bacterial cultures PMN count can exceed 1,000 cells/µL in severe cases Early Viral Meningitis or Encephalitis: PMNs may appear transiently before lymphocytes dominate Usually lower PMN counts compared to bacterial meningitis CNS Abscesses or Empyema: Localized infections leading to PMN infiltration Often accompanied by fever and focal neurological signs Trauma or Surgery: CNS disruption may cause increased PMNs due to inflammation or secondary infection Can persist for several days post-event Fungal or Tubercular Meningitis: Typically cause lymphocytic pleocytosis, but PMNs may appear in mixed infections or early disease stages Subarachnoid Hemorrhage (SAH): PMNs increase as part of the inflammatory response to blood in the subarachnoid space Usually accompanied by xanthochromia in CSF Clinical Implications PMNs in CSF are crucial for identifying acute CNS infections, particularly in distinguishing bacterial from viral meningitis. The degree of PMN elevation, along with other CSF parameters (glucose, protein, cell counts), helps determine the likelihood of bacterial infection. Interpretation Considerations Timing of lumbar puncture is crucial; very early in the course of meningitis, PMN counts may be deceptively low In partially treated bacterial meningitis, PMN counts might be lower than expected Repeated lumbar punctures may be necessary to track the progression of CSF findings Next Steps If PMNs are found in CSF, immediate consultation with a healthcare provider is essential. Further investigations, including CSF culture, PCR for pathogens, and neuroimaging, may be necessary. Prompt diagnosis and treatment are critical, especially for potentially life-threatening conditions like bacterial meningitis.
The CSF PMN % biomarker refers to the percentage of polymorphonuclear leukocytes (PMNs), commonly known as neutrophils, found in cerebrospinal fluid (CSF). PMNs are a type of white blood cell involved in the immune response, and their presence in CSF can indicate inflammation or infection within the central nervous system. Typically, CSF contains very few white blood cells, and a low PMN percentage is considered normal.
In the analysis of cerebrospinal fluid (CSF), the presence and count of red blood cells (RBCs) is a crucial diagnostic marker, particularly when assessed as part of a cell count with differential. Normally, CSF is devoid of RBCs, as it is a clear fluid that cushions the brain and spinal cord within the central nervous system (CNS). The detection of RBCs in CSF, a condition known as erythrocytosis, can be indicative of various pathological conditions. One of the most common causes of RBC presence in CSF is traumatic lumbar puncture, also known as a "bloody tap," where blood from a small vessel is inadvertently introduced into the sample during the procedure. However, excluding this procedural cause, the presence of RBCs in CSF is often associated with more serious conditions such as subarachnoid hemorrhage, where bleeding occurs into the space between the brain and the surrounding membrane. This can result from a ruptured aneurysm, trauma, or other vascular abnormalities. Additionally, RBCs in CSF can also indicate intracerebral or intraventricular hemorrhage, particularly in patients with stroke, head injury, or hypertension. In some cases, the presence of RBCs might also suggest inflammatory or neoplastic processes within the CNS, although these are less common causes. The interpretation of RBC counts in CSF requires careful consideration of the context, including patient history, clinical presentation, and other laboratory findings. For instance, the presence of xanthochromia, a yellowish discoloration of the CSF due to hemoglobin breakdown products, can help differentiate between a traumatic tap and genuine subarachnoid hemorrhage. Treatment and management strategies for RBCs in CSF focus primarily on addressing the underlying cause. For instance, in the case of subarachnoid hemorrhage, urgent medical or surgical intervention may be required to manage the bleeding source. In cases of traumatic tap, no specific treatment is necessary, but careful interpretation of the results is important to avoid misdiagnosis.
mature white blood cells
ß-Amyloid (1-42) is a peptide fragment derived from the amyloid precursor protein (APP) and is a critical biomarker in cerebrospinal fluid (CSF) for diagnosing and monitoring Alzheimer’s disease. In a healthy brain, ß-Amyloid (1-42) plays a role in normal neuronal function and synaptic plasticity. However, in Alzheimer’s disease, this peptide aggregates abnormally to form amyloid plaques, one of the hallmark pathological features of the condition. The reference range for ß-Amyloid (1-42) in cerebrospinal fluid (CSF) can vary slightly depending on the laboratory and assay used. However, typical ranges are: Normal Levels: Usually greater than 620 pg/mL (indicative of low risk for Alzheimer's disease). Reduced Levels (indicative of Alzheimer's disease): Less than 620 pg/mL, with lower values correlating with greater amyloid plaque deposition in the brain. Some laboratories or research studies may provide slightly different thresholds, but generally, levels below 620 pg/mL are considered a significant biomarker for Alzheimer’s disease. It's essential to interpret these values in the context of other CSF biomarkers, such as total tau and phosphorylated tau (pTau), for a more accurate diagnosis.
Normal CSF is crystal clear. However, as few as 200 white blood cells (WBCs) per mm3 or 400 red blood cells (RBCs) per mm3 will cause CSF to appear turbid (=cloudy). Xanthochromia is a yellow, orange, or pink discoloration of the CSF, most often caused by the lysis of RBCs resulting in hemoglobin breakdown to oxyhemoglobin, methemoglobin, and bilirubin. Discoloration begins after RBCs have been in spinal fluid for about two hours, and remains for two to four weeks. Xanthochromia is present in more than 90 percent of patients within 12 hours of subarachnoid hemorrhage onset (=bleeding in the space that surrounds the brain) and in patients with serum bilirubin levels between 10 to 15 mg per dL (171 to 256.5 μmol per L). CSF protein levels of at least 150 mg per dL (1.5 g per L)—as seen in many infectious and inflammatory conditions, or as a result of a traumatic tap that contains more than 100,000 RBCs per mm3—also will result in xanthochromia. Newborn CSF is often xanthochromic because of the frequent elevation of bilirubin and protein levels in this age group.
Tau/Tau-P Ratio is a cerebrospinal fluid (CSF) biomarker used to evaluate the relationship between total tau and phosphorylated tau (pTau), providing critical insights into the underlying pathology of neurodegenerative diseases, particularly Alzheimer’s disease. This ratio reflects both the extent of neuronal damage (indicated by total tau) and the degree of tau protein hyperphosphorylation (indicated by pTau). The Tau/Tau-P ratio enhances the diagnostic specificity of Alzheimer’s disease when interpreted alongside amyloid-beta (Aβ42) levels and other CSF biomarkers. It helps differentiate Alzheimer’s from other dementias or neurodegenerative conditions, making it a valuable tool in early diagnosis, treatment planning, and monitoring disease progression.
Count of all nucleated cells in cerebrospinal fluid from lumbar puncture.
Total Tau in CSF is a biomarker used to assess neuronal damage and degeneration, particularly in the context of neurodegenerative diseases. Tau is a protein primarily found in neurons, where it stabilizes microtubules essential for cellular transport. Elevated levels of total tau in cerebrospinal fluid (CSF) are often associated with conditions such as Alzheimer’s disease, where neuronal damage leads to the release of tau into the CSF. Increased tau can also indicate acute brain injuries, such as stroke, traumatic brain injury, or other neurodegenerative disorders. In Alzheimer’s disease, total tau is typically elevated alongside phosphorylated tau (pTau), which reflects pathological tau phosphorylation processes, distinguishing it from other neurodegenerative diseases. The measurement of total tau in CSF, combined with other markers like amyloid-beta (Aβ) peptides and pTau, provides valuable insights into the underlying pathology, aiding in early diagnosis, prognosis, and differentiation of dementia-related conditions.
Xanthochromia, in the context of cerebrospinal fluid (CSF) analysis, is a diagnostic marker of significant clinical importance, particularly when evaluated alongside a cell count with differential. Xanthochromia refers to the yellowish discoloration of the CSF, typically caused by the presence of bilirubin, a breakdown product of hemoglobin. This discoloration is not immediately apparent after a hemorrhagic event but develops several hours post-bleed as red blood cells (RBCs) degrade. The most critical clinical relevance of xanthochromia is its role in diagnosing subarachnoid hemorrhage (SAH). In SAH, bleeding occurs into the subarachnoid space (between the brain and the arachnoid membrane), often due to a ruptured cerebral aneurysm. Xanthochromia can reliably distinguish SAH from a traumatic lumbar puncture (LP), a procedure-related occurrence where RBCs are accidentally introduced into the CSF sample, as xanthochromia does not occur immediately after blood enters the CSF. In the analysis, xanthochromia is assessed through visual inspection and spectrophotometry, the latter providing more sensitive and specific results. Apart from SAH, xanthochromia can also be indicative of other pathological processes, such as prolonged elevated CSF protein levels, bilirubin metabolism disorders, and systemic diseases like jaundice. The presence of xanthochromia, especially when combined with other CSF findings like elevated RBC count or abnormal cell count with differential, necessitates a thorough diagnostic workup. In the case of SAH, urgent neurosurgical evaluation and intervention may be required. Treatment approaches for SAH focus on securing the bleeding source, managing cerebral vasospasm, and providing supportive care. Thus, xanthochromia in CSF is a crucial indicator, particularly in differentiating between traumatic LP and SAH, and guides the clinical management of various CNS conditions. Its assessment, in conjunction with other CSF parameters, forms an essential component of the diagnostic process in neurology and emergency medicine.